Simplifying Access to Targeted Protein Degraders via Nickel Electrocatalytic Cross‐CouplingPhilipp Neigenfind, Phil S. Baran, Luca Massaro et al.|Angewandte Chemie International Edition|2024Cited by 29
Development of BET Inhibitors as Potential Treatments for Cancer: Optimization of Pharmacokinetic PropertiesMatthew D. Hill, Andrew P. Degnan, Chunhong Yan et al.|ACS Medicinal Chemistry Letters|2022Cited by 10
Development of BET inhibitors as potential treatments for cancer: A new carboline chemotypeMatthew D. Hill, Andrew P. Degnan, Claude Quesnelle et al.|Bioorganic & Medicinal Chemistry Letters|2021Cited by 6
Simplifying Access to Targeted Protein Degraders via Nickel Electrocatalytic Cross‐CouplingPhilipp Neigenfind, Phil S. Baran, Luca Massaro et al.|Angewandte Chemie|2024Cited by 4
Simplifying Access to Targeted Protein Degraders via Ni-Electrocatalytic Cross-CouplingPhilipp Neigenfind, Phil S. Baran, Luca Massaro et al.|ChemRxiv|2023Cited by 3